tiprankstipranks
Trending News
More News >
NATCO Pharma Limited (IN:NATCOPHARM)
:NATCOPHARM
India Market

NATCO Pharma Limited (NATCOPHARM) Financial Statements

Compare
6 Followers

NATCO Pharma Limited Financial Overview

NATCO Pharma Limited's market cap is currently ₹157.19B. The company's EPS TTM is ₹22.85; its P/E ratio is 8.34; and it has a dividend yield of 0.68%. NATCO Pharma Limited is scheduled to report earnings on May 28, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 44.30B₹ 40.02B₹ 27.07B₹ 19.05B₹ 20.56B
Gross Profit₹ 29.10B₹ 31.39B₹ 20.80B₹ 12.23B₹ 15.24B
Operating Income₹ 19.61B₹ 25.96B₹ 8.76B₹ 2.20B₹ 9.31B
EBITDA₹ 25.50B₹ 18.80B₹ 10.40B₹ 3.63B₹ 6.07B
Net Income₹ 18.85B₹ 13.88B₹ 7.15B₹ 1.70B₹ 4.41B
Balance Sheet
Cash & Short-Term Investments₹ 24.97B₹ 17.78B₹ 11.62B₹ 7.60B₹ 8.10B
Total Assets₹ 86.31B₹ 69.06B₹ 56.57B₹ 51.09B₹ 47.92B
Total Debt₹ 2.79B₹ 3.86B₹ 1.67B₹ 4.32B₹ 2.84B
Net Debt₹ -18.97B₹ 3.16B₹ 348.00M₹ 3.21B₹ 2.58B
Total Liabilities₹ 10.19B₹ 10.53B₹ -34.80B₹ 8.46B₹ 6.68B
Stockholders' Equity₹ 76.07B₹ 58.53B₹ 48.74B₹ 42.64B₹ 41.22B
Cash Flow
Free Cash Flow₹ 14.28B₹ 8.53B₹ 6.43B₹ -1.96B₹ 442.00M
Operating Cash Flow₹ 18.29B₹ 12.12B₹ 8.49B₹ 465.00M₹ 2.99B
Investing Cash Flow₹ -15.64B₹ -10.33B₹ -4.77B₹ -53.00M₹ -1.03B
Financing Cash Flow₹ -1.93B₹ -2.47B₹ -3.63B₹ 348.00M₹ -1.86B
Currency in INR

NATCO Pharma Limited Earnings and Revenue History

NATCO Pharma Limited Debt to Assets

NATCO Pharma Limited Cash Flow

NATCO Pharma Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis